Acadian Asset Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Sell |
186,692
-350,095
| -65% | -$3.49M | ﹤0.01% | 849 |
|
|
2025
Q1 | $3.2M | Buy |
536,787
+66,641
| +14% | +$398K | 0.01% | 622 |
|
|
2024
Q4 | $3.61M | Buy |
470,146
+453,245
| +2,682% | +$3.48M | 0.01% | 609 |
|
|
2024
Q3 | $172K | Buy |
+16,901
| New | +$172K | ﹤0.01% | 1415 |
|
|
2024
Q2 | – | Sell |
-244,712
| Closed | -$3.34M | – | 1832 |
|
|
2024
Q1 | $3.34M | Buy |
+244,712
| New | +$3.34M | 0.01% | 555 |
|
|
2023
Q1 | – | Sell |
-23,159
| Closed | -$451K | – | 1847 |
|
|
2022
Q4 | $451K | Sell |
23,159
-238,407
| -91% | -$4.64M | ﹤0.01% | 1064 |
|
|
2022
Q3 | $4.98M | Sell |
261,566
-29,173
| -10% | -$556K | 0.03% | 397 |
|
|
2022
Q2 | $5.99M | Buy |
290,739
+164,540
| +130% | +$3.39M | 0.03% | 367 |
|
|
2022
Q1 | $4.06M | Buy |
126,199
+118,702
| +1,583% | +$3.82M | 0.02% | 508 |
|
|
2021
Q4 | $347K | Buy |
+7,497
| New | +$347K | ﹤0.01% | 1103 |
|